Signaling pathways
-
BA3631 S29434Summary: S29434 (NMDPEF) is a potent, competitive, selective, cell membrane-permeable quinone reductase 2 inhibitor. -
BA2317 IzeltabartSummary: Izeltabart is a high affinity humanized antibody that targets. -
BA2319 BriobaceptSummary: Briobacept (BR3FC) is a selectively targeted monoclonal antibody that induces apoptosis in B cells. -
BA2321 MertansineSummary: A maytansinoid microtubule inhibitor that can be conjugated to monoclonal antibodies for antibody-drug conjugates (ADC) -
BA2323 DM4Summary: DM4 is an anti-microtubule protein agent that inhibits cell division. -
BA2329 CC-885-CH2-PEG1-NH-CH3Summary: CC-885-CH2-PEG1-NH-CH3 is a new degradant. -
BA2330 PF-06380101Summary: PF-06380101 (Aur0101), a microtubule inhibitor. -
BA2333 T01-1Summary: T01-1 is an anticancer agent (camptothecin derivative). -
BA2334 MMAF-OMeSummary: MMAF-Ome is a tubulin inhibitor, a toxic molecule belonging to the ADC, and is able to inhibit four tumor cells, MDAMB435/5T4, MDAMB361DYT2, MDAMB468, and Raji(5T4). -
BA2335 DocetaxalSummary: Docetaxal (10-Acetyldocetaxel) is an analog.

